The American Cancer Society has updated guidelines for colon cancer screening. (You can find the exact guidelines here.) Also today, there is eye-opening new data in spondyloarthritis, psoriasis therapy with biologics is not associated with an increased risk for cancer, and testosterone therapy may impact kidney stone risk. 

In postmenopausal women, a higher level of testosterone, in comparison with estrogen, may increase the cardiovascular risk later in life. Also today, renal denervation as a treatment option for hypertension may be rebounding, psoriatic arthritis has effects beyond just physical, and opioids are still being overprescribed for postoperative pain management. 

Female Physicians are at higher risk for burnout compared with their male counterparts. Also today, post-op delirium management has been proposed as a performance measure in hospitals, the NIH launches an early Ebola treatment trial, and new agents may bring hope for patients with SLE. Listen to the MDedge Daily News podcast for all the details on today’s top news.

The MDedge Daily news is four of the top stories from around MDedge.com for clinicians, students, and researchers. Narrated by Nick Andrews, Terry Rudd, and Mary Ellen Schneider.

Today's stories are:

Genes, not adiposity, may be driving appetite differences in obesity.

https://www.mdedge.com/internalmedicinenews/article/166564/obesity/genes-not-adiposity-may-be-driving-appetite-differences

Conservative early approach likely best, RA expert says

https://www.mdedge.com/internalmedicinenews/article/166553/rheumatoid-arthritis/conservative-early-approach-likely-best-ra

Spotlight on nonmelanoma skin cancer’s true burden

https://www.mdedge.com/internalmedicinenews/article/166535/nonmelanoma-skin-cancer/spotlight-nonmelanoma-skin-cancers-true

Atopic eczema linked to cardiovascular disease risk

https://www.mdedge.com/internalmedicinenews/article/166484/atopic-dermatitis/atopic-eczema-linked-cardiovascular-disease

Memorial Day is the traditional kick-off to summer, so patients will need information on some important topics. To that end, the Food and Drug Administration reminds that there is no such thing as a supplement that prevents sun damage. The CDC warns that nasty things happen when people (kids) drink the pool water. And the federal government advises on what should be included in an approved insect repellent.

The MDedge Daily news is four of the top stories from around MDedge.com for clinicians, students, and researchers. Narrated by Nick Andrews, Terry Rudd, and Mary Ellen Schneider.

Today's stories are:

Breakthrough in noninvasive assessment of multivessel CAD

https://www.mdedge.com/internalmedicinenews/article/166470/interventional-cardiology-surgery/breakthrough-noninvasive

Uptake of lung cancer screening is exceedingly low

https://www.mdedge.com/internalmedicinenews/article/166457/lung-cancer/uptake-lung-cancer-screening-exceedingly-low

Hefty rewards pay off in smoking-cessation study

https://www.mdedge.com/internalmedicinenews/article/166479/addiction-medicine/hefty-rewards-pay-smoking-cessation-study

Congress passes ‘right to try’ legislation

https://www.mdedge.com/internalmedicinenews/article/166471/practice-management/congress-passes-right-try-legislation

Children whose autism was not detected by M-CHAT at 18 months old were more likely to have delays in social, communication, and fine and gross motor skills at the time of the screen. Also today, TAVR is safe in low-risk aortic stenosis, GLP-1 receptor agonists are effective in elderly patients, and IBD upped the risk for Parkinson's. 

Roseomonas mucosa bacteria obtained from healthy volunteers without atopic dermatitis reduced the severity of the disorder in a small, early-phase study of 10 adults and 5 children with atopic dermatitis. Also today, a new device could detect osteoarthritis with sound and motion, seven days of antibiotics is enough for gram-negative bacteremias, and canagliflozen is linked to lower HbA1c levels in younger patients.

Pills alone are not the answer for pain management, canagliflozin's HbA1c effect muted over time by placebo group effects. most COPD patients on triple therapy can withdraw steroids, and specialty practices hire more physicians assistants and nurse practitioners.